Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies

BACKGROUND: Treatment of everolimus-resistant disease remains largely undefined in metastatic renal cell carcinoma (mRCC). We report on 40 patients (pts) who receive systemic treatment after failure of everolimus. PATIENTS AND METHODS: Forty pts received sunitinib (n=19), sorafenib (n=8), dovitinib...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Grünwald, V, Seidel, C, Fenner, M, Ganser, A, Busch, J, Weikert, S
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2011
Témata:
Short Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242587/
https://ncbi.nlm.nih.gov/pubmed/22033275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.389
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky